Abstract
This paper reviews recent research on the contribution of the proinflammatory cytokine interleukin-1β (IL-1β) and the purine nucleoside adenosine in mediating behavioral depression and related symptoms of conservation-withdrawal in animal models of traumatic stress, major depression, and illness. Activation of brain IL-1β receptors appears to contribute to conservation-withdrawal by exacerbating the immediate impact of a stressor or by enhancing and prolonging the overall reaction. Moreover, brain cytokine signaling is capable of recruiting adenosine signaling at A2A, which directly mediates symptoms of behavioral depression. The adenosine receptors densely populate spiny GABAergic neurons in the striopallidal tract in the striatum and form part of an A2A/D2/mGLU receptor complex. Activation of these A2A receptors functionally uncouples dopamines excitatory motivation influence on ongoing behavior, leading to a state of conservation- withdrawal.
Keywords: ATP, Adenosine receptors, adenosine receptor antagonists, shock, Reserpine, DMSO
CNS & Neurological Disorders - Drug Targets
Title: Cytokine-Purine Interactions in Traumatic Stress, Behavioral Depression,and Sickness
Volume: 5 Issue: 5
Author(s): Thomas R. Minor, Qingjun Huang and Alexis E. Witt
Affiliation:
Keywords: ATP, Adenosine receptors, adenosine receptor antagonists, shock, Reserpine, DMSO
Abstract: This paper reviews recent research on the contribution of the proinflammatory cytokine interleukin-1β (IL-1β) and the purine nucleoside adenosine in mediating behavioral depression and related symptoms of conservation-withdrawal in animal models of traumatic stress, major depression, and illness. Activation of brain IL-1β receptors appears to contribute to conservation-withdrawal by exacerbating the immediate impact of a stressor or by enhancing and prolonging the overall reaction. Moreover, brain cytokine signaling is capable of recruiting adenosine signaling at A2A, which directly mediates symptoms of behavioral depression. The adenosine receptors densely populate spiny GABAergic neurons in the striopallidal tract in the striatum and form part of an A2A/D2/mGLU receptor complex. Activation of these A2A receptors functionally uncouples dopamines excitatory motivation influence on ongoing behavior, leading to a state of conservation- withdrawal.
Export Options
About this article
Cite this article as:
Minor R. Thomas, Huang Qingjun and Witt E. Alexis, Cytokine-Purine Interactions in Traumatic Stress, Behavioral Depression,and Sickness, CNS & Neurological Disorders - Drug Targets 2006; 5 (5) . https://dx.doi.org/10.2174/187152706778559282
DOI https://dx.doi.org/10.2174/187152706778559282 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vasoactive Intestinal Peptide in Neurodevelopmental Disorders:Therapeutic Potential
Current Pharmaceutical Design Depression Under the Perspective of Oxytocin
Central Nervous System Agents in Medicinal Chemistry Re-Wiring the Circuit: Mitochondria as a Pharmacological Target in Liver Disease
Current Medicinal Chemistry Recent Advances in Fe-MOF Compositions for Biomedical Applications
Current Medicinal Chemistry Patenting of Nanopharmaceuticals in Drug Delivery: No Small Issue
Recent Patents on Drug Delivery & Formulation PPARα/HNF4α Interplay on Diversified Responsive Elements. Relevance in the Regulation of Liver Peroxisomal Fatty Acid Catabolism
Current Drug Metabolism Ghrelin and Growth Hormone Secretagogues, Physiological and Pharmacological Aspect
Current Drug Discovery Technologies <i>Nigella Sativa</i> (Black Seeds), A Potential Herb for the Pharmacotherapeutic Management of Hypertension - A Review
Current Cardiology Reviews Innovative Opioid Peptides and Biased Agonism: Novel Avenues for More Effective and Safer Analgesics to Treat Chronic Pain
Current Medicinal Chemistry Histone Deacetylase Inhibitors and Neurodegenerative Disorders: Holding the Promise
Current Pharmaceutical Design Nitric Oxide: Friendly Rivalry in Tuberculosis
Current Signal Transduction Therapy Physical Activity and Hypertension: Evidence of Cross-Sectional Studies,Cohort Studies and Meta-Analysis
Current Hypertension Reviews Inflammatory Mediators in Smoke Inhalation Injury
Inflammation & Allergy - Drug Targets (Discontinued) Molecular Pathways Involved in Apoptotic Cell Death in the Injured Cochlea: Cues to Novel Therapeutic Strategies
Current Pharmaceutical Design GABA Puts a Stop to Pain
Current Drug Targets - CNS & Neurological Disorders Progress in Understanding Basal Ganglia Dysfunction as a Common Target for Methamphetamine Abuse and HIV-1 Neurodegeneration
Current HIV Research Utility of the Electrocardiogram in Drug Overdose and Poisoning: Theoretical Considerations and Clinical Implications
Current Cardiology Reviews Cytochrome P450 and the Biological Clock in Mammals
Current Drug Metabolism Current Diagnostic Modalities for Vulnerable Plaque Detection
Current Pharmaceutical Design Rasburicase: A New Approach for Preventing and/or Treating Tumor Lysis Syndrome
Current Pharmaceutical Design